EUVIMEDEUVIMED entdecken
Crossref

Phagophobia in oral anticancer medication management: Utilizing NCODA resources in Irish oncology clinical practice

Darren J. Walsh, Natasha Olson

NCODA Oncology and Hematology Meeting Abstracts · 13.10.2026 · 2 (2)

DOI: 10.67209/sjzx4769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NCODA Oncology and Hematology Meeting Abstracts, online erschienen am 13.10.2026. Verfasst von Darren J. Walsh und 1 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A female patient presented to the medical oncology clinic for consideration of adjuvant systemic anticancer therapy (SACT) following complete resection of cholangiocarcinoma with oral capecitabine as per the BILCAP study. This patient had significant phagophobia, a fear of swallowing tablets, and exhibited a reluctance to engage with oral therapy. The patient also had a heterozygous dihydropyrimidine dehydrogenase (DPYD) deficiency, requiring an upfront dose reduction and additional counseling for toxicity risk.

Objective

Optimize curative treatment options for patients with phagophobia. Reassure the patient of non-conventional methods of administration. Educate the patient and family in relation to alternative methods of administration.

Methods

Alternative options assessed included (1) multiples of smaller tablet strengths, (2) crushing capecitabine tablets, and (3) parenteral SACT. Product literature was consulted to assess tablet strength. The Network for Collaborative Oncology Development & Advancement (NCODA) Oral Oncolytic Crush/Suspension Tool was consulted for crushing capecitabine tablets. The National Cancer Control Programme SACT regimen database was consulted for alternative parenteral SACT regimens in the adjuvant cholangiocarcinoma setting.

Results

The options were discussed with the patient and her primary caregiver (daughter). The patient and her daughter were counseled and educated on crushing tablets using the instructions contained within the NCODA crushing database. This information was shared with the oral anticancer medication clinic, the patient’s community pharmacy, and primary care physician to ensure appropriate dissemination of material.

Conclusion

NCODA resources can be invaluable in overcoming clinical challenges in outpatient oncology clinics in Irish clinical practice, including phagophobia. These resources provide pharmacists with the tools to navigate these challenges and optimize patient care, educate patients and caregivers, and ensure reliable information dissemination between tertiary and primary care in relation to high-risk medication use in community settings. Funding: Not Applicable.

Zitieren

APA

Walsh, D. J., & Olson, N. (2026). Phagophobia in oral anticancer medication management: Utilizing NCODA resources in Irish oncology clinical practice. NCODA Oncology and Hematology Meeting Abstracts, 2(2). https://doi.org/10.67209/sjzx4769

Vancouver

Walsh DJ, Olson N. Phagophobia in oral anticancer medication management: Utilizing NCODA resources in Irish oncology clinical practice. NCODA Oncology and Hematology Meeting Abstracts. 2026;2(2). doi:10.67209/sjzx4769

BibTeX
@article{Walsh2026,
  author = {Walsh, Darren J. and Olson, Natasha},
  title = {Phagophobia in oral anticancer medication management: Utilizing NCODA resources in Irish oncology clinical practice},
  journal = {NCODA Oncology and Hematology Meeting Abstracts},
  year = {2026},
  volume = {2},
  number = {2},
  doi = {10.67209/sjzx4769}
}
Kostenlos starten →